STOCKHOLM, Sweden, May 03, 2005 (PRIMEZONE) -- Medicover January:
- Revenue for the first quarter ending 31 March 2005 amounted to Euro 13.2 million (Euro 9.7 million), representing 36 percent revenue growth versus last year. Excluding the acquisition effect, the revenue growth was 33 percent.
- Constant currency revenue growth amounted to 21 percent and excluding acquisitions, 19 percent.
- Membership growth was robust with 11,700 (5,000) new members for the quarter, bringing total members to 151,600 (122,000).
- The operating profit before depreciation and amortization (EBITDA) for the quarter amounted to Euro 1.1 million (Euro 0.6 million) or 8.6 percent (6.5 percent) of revenue.
- The operating profit (EBIT) for the quarter amounted to Euro 0.3 million (loss Euro 0.2 million).
- The profit after tax for the quarter amounted to Euro 36,000 (loss Euro 0.2 million), equivalent to a profit per share of Euro 0.003 (loss Euro 0.014) and the diluted profit per share was Euro 0.003 (loss Euro 0.014).
- Net cash inflow from operating activities after tax payments was Euro 0.3 million (outflow Euro 0.1 million) for the quarter.
- In April, we announced an additional acquisition in the Polish laboratory market and a proposed rights issue of about SEK 107 million to finance further strong expansion.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=94839&fn=wkr0001.pdf